Spots Global Cancer Trial Database for rising psa
Every month we try and update this database with for rising psa cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer | NCT04428203 | Prostate Cancer... Prostate Cancer Prostate Adenoc... | Epidiolex Oral ... | 18 Years - | University of Kentucky | |
| Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer | NCT00694291 | Prostate Cancer | Sorafenib Placebo | 18 Years - | Fox Chase Cancer Center | |
| Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer | NCT00582140 | Prostate Cancer | pTVG-HP with rh... pTVG-HP with rh... pTVG-HP with rh... | 18 Years - | University of Wisconsin, Madison | |
| Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC) | NCT01171898 | Prostate Cancer | ARN-509 (Phase ... ARN-509 (Phase ... | 18 Years - | Aragon Pharmaceuticals, Inc. | |
| Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy | NCT03388619 | Cancer Of Prost... Prostate Neopla... Prostate Cancer Neoplasms of Pr... Prostatic Cance... | Prostate bed wi... Prostate bed ir... Whole Body Bone... 18F-NaF PET Ima... CT mpMRI ADT | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Molecular Studies and Clinical Correlations in Human Prostatic Disease | NCT00578240 | Prostate Cancer | - | Memorial Sloan Kettering Cancer Center | ||
| Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer | NCT00582140 | Prostate Cancer | pTVG-HP with rh... pTVG-HP with rh... pTVG-HP with rh... | 18 Years - | University of Wisconsin, Madison | |
| Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy | NCT00148772 | Prostate Cancer | Erlotinib (Tarc... | 18 Years - | NorthShore University HealthSystem | |
| Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer | NCT00658697 | Prostate Cancer | Docetaxel Bevacizumab ADT Bicalutamide | 18 Years - | Dana-Farber Cancer Institute | |
| Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy | NCT00148772 | Prostate Cancer | Erlotinib (Tarc... | 18 Years - | NorthShore University HealthSystem | |
| Molecular Studies and Clinical Correlations in Human Prostatic Disease | NCT00578240 | Prostate Cancer | - | Memorial Sloan Kettering Cancer Center | ||
| A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy | NCT00887458 | Prostate Cancer | Itraconazole 20... Itraconazole 30... | 18 Years - | Johns Hopkins University | |
| PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma | NCT01304485 | Prostate Cancer | Sodium Acetate ... | 18 Years - | Phoenix Molecular Imaging | |
| A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy | NCT00887458 | Prostate Cancer | Itraconazole 20... Itraconazole 30... | 18 Years - | Johns Hopkins University | |
| Molecular Studies and Clinical Correlations in Human Prostatic Disease | NCT00578240 | Prostate Cancer | - | Memorial Sloan Kettering Cancer Center | ||
| Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA) | NCT01118741 | Prostate Cancer | Disulfiram | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer | NCT01317199 | Prostate Cancer | Muscadine Plus ... Low-dose MPX High-dose MPX Placebo oral ca... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma | NCT01304485 | Prostate Cancer | Sodium Acetate ... | 18 Years - | Phoenix Molecular Imaging | |
| ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body | NCT00061126 | Prostate Cancer | ABX-EGF | 18 Years - | Abgenix | |
| Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer | NCT04428203 | Prostate Cancer... Prostate Cancer Prostate Adenoc... | Epidiolex Oral ... | 18 Years - | University of Kentucky |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
